Key result
A 48-year-old patient with late-onset Miyoshi myopathy presented with novel dysferlin gene mutations and severe atrophy in the soleus and medial gastrocnemius muscles on computed tomography.
Case Report (n=1)
Highlights the importance of testing for dysferlin gene mutations in older patients presenting with posterior compartment atrophy of distal lower extremities and elevated serum creatine kinase.
Answers are grounded in this paper and cite their sources.
May prompt dysferlin testing in late-onset distal leg atrophy; leaves open generalizability and needs validation in larger cohorts.
Miyoshi myopathy is characterized by weakness of the calf muscles during early adulthood. We report a case of late-onset Miyoshi myopathy presenting at 48 years of age, with novel mutations in the dysferlin gene. Muscle computed tomography clearly revealed severe atrophy in the soleus and medial gastrocnemius muscles. Even older patients with atrophy in the posterior compartment of the distal lower extremities and a relatively high serum creatine kinase level should be examined for the dysferlin gene.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2004) conducted a case report in Late-onset Miyoshi myopathy (n=1). Novel dysferlin gene mutations was evaluated on Muscle atrophy in the soleus and medial gastrocnemius muscles. A 48-year-old patient with late-onset Miyoshi myopathy presented with novel dysferlin gene mutations and severe atrophy in the soleus and medial gastrocnemius muscles on computed tomography.
Synapse has enriched 10 related papers. Consider them for comparative context: